Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to $93000.0.

  • Utah Medical Products' Other Working Capital Changes rose 113333.33% to $93000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $34000.0, marking a year-over-year increase of 14250.0%. This contributed to the annual value of $3000.0 for FY2024, which is 65000.0% up from last year.
  • According to the latest figures from Q3 2025, Utah Medical Products' Other Working Capital Changes is $93000.0, which was up 113333.33% from -$171000.0 recorded in Q2 2025.
  • Utah Medical Products' 5-year Other Working Capital Changes high stood at $109000.0 for Q1 2021, and its period low was -$171000.0 during Q2 2025.
  • For the 5-year period, Utah Medical Products' Other Working Capital Changes averaged around $4210.5, with its median value being $21000.0 (2021).
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first crashed by 70000.0% in 2024, then skyrocketed by 113333.33% in 2025.
  • Over the past 5 years, Utah Medical Products' Other Working Capital Changes (Quarter) stood at $46000.0 in 2021, then rose by 28.26% to $59000.0 in 2022, then plummeted by 144.07% to -$26000.0 in 2023, then surged by 430.77% to $86000.0 in 2024, then increased by 8.14% to $93000.0 in 2025.
  • Its last three reported values are $93000.0 in Q3 2025, -$171000.0 for Q2 2025, and $26000.0 during Q1 2025.